FDA Adverse Event Injury Summary report: N

SHOCKWAVE M5+ PERIPHERAL INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER

MDR report key: 19726410 · Received July 11, 2024

Report

Report Number
3015053858-2024-00068
Event Type
Injury
Date Received
July 11, 2024
Date of Event
June 13, 2024
Report Date
July 11, 2024
Manufacturer
SHOCKWAVE MEDICAL, INC.
Product Code
PPN
PMA / PMN Number
K203365
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE REFERENCED IN THIS REPORT WAS NOT RETURNED TO SHOCKWAVE MEDICAL, INC. THEREFORE, A PHYSICAL EXAMINATION CANNOT BE PERFORMED. THERE WAS NO IVL DEVICE MALFUNCTION REPORTED. THE CAUSE OF THE TACHYCARDIA COULD NOT BE DETERMINED BASED ON THE INFORMATION AVAILABLE. THE LOT NUMBER OF THE DEVICE WAS NOT PROVIDED. THEREFORE, REVIEW OF THE DEVICE MANUFACTURING AND TEST DOCUMENTATION COULD NOT BE COMPLETED. HOWEVER, SHOCKWAVE MEDICAL, INC. HAS CONTROLS IN PLACE TO ENSURE DEVICES ARE BUILT TO APPROVED PROCEDURES AND MEET LOT RELEASE ACCEPTANCE CRITERIA PRIOR TO DISTRIBUTION.

Description of Event or Problem · 0

A SHOCKWAVE M5+ PERIPHERAL INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER WAS USED TO A LESION IN THE SUPERFICIAL FEMORAL ARTERY (SFA). THE PATIENT'S HEART RATE INCREASED TO 120 TO 130 BPM AND THE PATIENT BECAME TACHYCARDIAC. THE REPORTED TACHYCARDIA STOPPED SHORTLY AFTER THE IVL TREATMENT WAS STOPPED AND THE PATIENTS' SINUS RHYTHM WAS RESTORED. THE PHYSICIAN DID NOT CONTINUE THE LITHOTRIPSY TREATMENT. NO FURTHER PATIENT HARM AND NO IVL DEVICE MALFUNCTION REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
315905 SHOCKWAVE M5+ PERIPHERAL INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER SHOCKWAVE M5+ PERIPHERAL INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER PPN SHOCKWAVE MEDICAL, INC. M5PIVL5060 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other